Your activity: 148 p.v.
< Back
Adjuvant therapy for muscle-invasive urothelial carcinoma of the bladder
Bladder preservation treatment options for muscle-invasive urothelial bladder cancer
Chemoprevention of urothelial carcinoma of the bladder
Clinical presentation, diagnosis, and staging of bladder cancer
Epidemiology and risk factors of urothelial (transitional cell) carcinoma of the bladder
Infectious complications of intravesical BCG immunotherapy
Malignancies of the renal pelvis and ureter
Management of recurrent or persistent non-muscle invasive bladder cancer
Molecular biology of bladder cancer
Neoadjuvant treatment options for muscle-invasive urothelial bladder cancer
Non-urothelial bladder cancer
Overview of the initial approach and management of urothelial bladder cancer
Overview of the management of bladder cancer in older adults
Pathology of bladder neoplasms
Radical cystectomy
Screening for bladder cancer
Small cell carcinoma of the bladder
Treatment of metastatic urothelial cancer of the bladder and urinary tract
Treatment of primary non-muscle invasive urothelial bladder cancer
Urinary diversion and reconstruction following cystectomy
Urine biomarkers for the detection of urothelial (transitional cell) carcinoma of the bladder
Cancer of the ovary, fallopian tube, and peritoneum: Surgical cytoreduction
Cervical cancer screening tests: Techniques for cervical cytology and human papillomavirus testing
Cervical cancer screening: The cytology and human papillomavirus report
Epithelial carcinoma of the ovary, fallopian tube, and peritoneum: Clinical features and diagnosis
Epithelial carcinoma of the ovary, fallopian tube, and peritoneum: Histopathology
Epithelial carcinoma of the ovary, fallopian tube, and peritoneum: Incidence and risk factors
Epithelial carcinoma of the ovary, fallopian tube, and peritoneum: Surgical staging
First-line chemotherapy for advanced (stage III or IV) epithelial ovarian, fallopian tube, and peritoneal cancer
Gestational trophoblastic disease: Pathology
Hydatidiform mole: Epidemiology, clinical features, and diagnosis
Hydatidiform mole: Treatment and follow-up
Initial management of low-risk gestational trophoblastic neoplasia
Medical treatment for relapsed epithelial ovarian, fallopian tube, or peritoneal cancer: Platinum-resistant disease
Medical treatment for relapsed epithelial ovarian, fallopian tube, or peritoneal cancer: Platinum-sensitive disease
Ovarian germ cell tumors: Pathology, epidemiology, clinical manifestations, and diagnosis
Overview of epithelial carcinoma of the ovary, fallopian tube, and peritoneum
Patient selection and approach to neoadjuvant chemotherapy for newly diagnosed advanced ovarian cancer
Preinvasive and invasive cervical neoplasia in patients with HIV infection
Screening for ovarian cancer
Sex cord-stromal tumors of the ovary: Epidemiology, clinical features, and diagnosis in adults
Sex cord-stromal tumors of the ovary: Management in adults
Struma ovarii
Treatment of malignant germ cell tumors of the ovary
Uterine sarcoma: Classification, epidemiology, clinical manifestations, and diagnosis
Vaginal cancer
Vaginal intraepithelial neoplasia
Vulvar cancer: Epidemiology, diagnosis, histopathology, and treatment
Vulvar squamous intraepithelial lesions (vulvar intraepithelial neoplasia)
Renal angiomyolipomas (AMLs): Epidemiology, pathogenesis, clinical manifestations, and diagnosis
Renal angiomyolipomas (AMLs): Management
Renal manifestations of tuberous sclerosis complex
Carcinoma of the penis: Clinical presentation, diagnosis, and staging
Carcinoma of the penis: Epidemiology, risk factors, and pathology
Carcinoma of the penis: Surgical and medical treatment
Active surveillance for males with clinically localized prostate cancer
Alternative endocrine therapies for castration-resistant prostate cancer
Bone metastases in advanced prostate cancer: Clinical manifestations and diagnosis
Bone metastases in advanced prostate cancer: Management
Brachytherapy for low-risk or favorable intermediate-risk, clinically localized prostate cancer
Castration-resistant prostate cancer: Treatments targeting the androgen pathway
Chemoprevention strategies in prostate cancer
Chemotherapy in advanced castration-resistant prostate cancer
Clinical presentation and diagnosis of prostate cancer
Cryotherapy and other ablative techniques for the initial treatment of prostate cancer
External beam radiation therapy for localized prostate cancer
Follow-up surveillance after definitive local treatment for prostate cancer
Genetic risk factors for prostate cancer
Immunotherapy for castration-resistant prostate cancer
Initial approach to low- and very low-risk clinically localized prostate cancer
Initial management of regionally localized intermediate-, high-, and very high-risk prostate cancer and those with clinical lymph node involvement
Initial staging and evaluation of males with newly diagnosed prostate cancer
Initial systemic therapy for advanced, recurrent, and metastatic noncastrate (castration-sensitive) prostate cancer
Interpretation of prostate biopsy
Localized prostate cancer: Risk stratification and choice of initial treatment
Management of advanced prostate cancer with germline or somatic homologous recombination repair deficiency
Measurement of prostate-specific antigen
Molecular biology of prostate cancer
Molecular prognostic tests for prostate cancer
Overview of systemic treatment for advanced, recurrent and metastatic castration-sensitive prostate cancer and local treatment for patients with metastatic disease
Overview of the treatment of castration-resistant prostate cancer (CRPC)
Patient education: Prostate cancer screening (Beyond the Basics)
Precancerous lesions of the prostate: Pathology and clinical implications
Prostate cancer in older males
Prostate cancer: Postoperative management of pathologic stage T3 disease, positive surgical margins, and lymph node involvement following radical prostatectomy
Radiation proctitis: Clinical manifestations, diagnosis, and management
Radical prostatectomy for localized prostate cancer
Rising or persistently elevated serum PSA following radical prostatectomy for prostate cancer: Management
Rising serum PSA after radiation therapy for localized prostate cancer: Salvage local therapy
Rising serum PSA following local therapy for prostate cancer: Definition, natural history, and risk stratification
Rising serum PSA following local therapy for prostate cancer: Diagnostic evaluation
Risk factors for prostate cancer
Role of systemic therapy in patients with a biochemical recurrence after treatment for localized prostate cancer
Side effects of androgen deprivation therapy
The role of magnetic resonance imaging in prostate cancer
Antiangiogenic and molecularly targeted therapy for advanced or metastatic clear cell renal carcinoma
Clinical features, diagnosis, and management of von Hippel-Lindau disease
Clinical manifestations, evaluation, and staging of renal cell carcinoma
Definitive surgical management of renal cell carcinoma
Diagnostic approach, differential diagnosis, and management of a small renal mass
Epidemiology, pathology, and pathogenesis of renal cell carcinoma
Evaluation of the incidental kidney lesion
Hereditary kidney cancer syndromes
Molecular biology and pathogenesis of von Hippel-Lindau disease
Overview of the treatment of renal cell carcinoma
Prognostic factors in patients with renal cell carcinoma
Radiofrequency ablation and cryoablation for renal cell carcinoma
Renal cell carcinoma with sarcomatoid features
Role of surgery in patients with metastatic renal cell carcinoma
Surveillance for metastatic disease after definitive treatment for renal cell carcinoma
Systemic therapy of advanced clear cell renal carcinoma
The treatment of advanced non-clear cell renal carcinoma
Urinary tract malignancy and atherosclerotic disease in patients with chronic analgesic abuse
Urinary tract malignancy and atherosclerotic disease in patients with chronic analgesic abuse
Active surveillance following orchiectomy for stage I testicular germ cell tumors
Anatomy and pathology of testicular tumors
Approach to surgery following chemotherapy for advanced testicular germ cell tumors
Approach to the care of long-term testicular cancer survivors
Clinical manifestations, diagnosis, and staging of testicular germ cell tumors
Diagnosis and treatment of relapsed and refractory testicular germ cell tumors
Effects of cytotoxic agents on gonadal function in adult men
Epidemiology of and risk factors for testicular germ cell tumors
Extragonadal germ cell tumors involving the mediastinum and retroperitoneum
Initial risk-stratified treatment for advanced testicular germ cell tumors
Intracranial germ cell tumors
Management of stage I nonseminomatous germ cell tumors
Management of stage II nonseminomatous germ cell tumors
Overview of the treatment of testicular germ cell tumors
Posttreatment follow-up for men with testicular germ cell tumors
Radical inguinal orchiectomy for testicular germ cell tumors
Retroperitoneal lymph node dissection for early-stage testicular germ cell tumors
Serum tumor markers in testicular germ cell tumors
Testicular germ cell neoplasia in situ
Testicular sex cord stromal tumors
Treatment of stage I seminoma
Treatment of stage II seminoma
Treatment-related toxicity in men with testicular germ cell tumors
Urethral cancer